Resources

An insightful discussion about different weight loss strategy approaches, including insights on why some nutrition-first programs work when others fail.

Health plan and benefits leaders need to prepare for what’s next when it comes to managing consumer demand and rising healthcare costs related to GLP-1s for weight loss. Get answers to top GLP-1 questions.

Market, clinical and actuarial insights about how to avoid wasted GLP-1 pharmacy spend

This new whitepaper provides valuable insights for leaders looking to optimize the impact of GLP-1 investments

Hear real world stories from members on their Virta journey and learn best practices for driving engagement in benefits programs.

ACHP members are partnering with Virta on diabetes and obesity reversal to improve clinical outcomes and lower healthcare costs.

A recap of new GLP-1 research to help you make sense of the new information seeming to hit the news (and your inbox) almost daily

Experts weigh in on the results of a new survey on GLP-1 trends from 300 PCPs, endocrinologists and obesity-certified specialists.

New survey of 300 PCPs, endocrinologists and obesity-certified specialists explores what’s really happening between the patients asking for weight loss drugs and the physicians supporting them.

Insights for building a GLP-1 strategy and optimizing for cost and member experience.

With new anti-obesity meds in the pipeline, including oral GLP-1s, and healthcare costs rising exponentially—what happens next?

A first of its kind research study from Virta Health shows sustained weight loss after deprescribing GLP-1s among a real world population.